COVID-19 monoclonal antibody treatment impact on symptoms and post-COVID conditions among high-risk patients at a Federally Qualified Health Center by Natalie L. Vawter, Job G. Godino, Sydney V. Lewis, Adam W. Northrup, Jane C. Samaniego, Jacqueline Y. Poblete, Jesus A. Guereca, Sydney P. Sharp, Eva Matthews, Noe C. Crespo, Pauline G. Lucatero, Monica M. Vidaurrazaga, Christian B. Ramers

Get full text